Research News
View articles by month and year
-
Long-Term Bisphosphonate Use Linked to Atypical Fracture Risk
Women who take bisphosphonates for more than 5 years have a higher risk of breaking a leg bone in an unusual spot.
-
Waiting 5 Years to Start Hormone Replacement Therapy Offers Less Risk
New research suggests that breast cancer risk is higher in women who use HRT during the first 5 years after menopause starts compared to women who wait more than 5 years to start HRT.
-
Lexapro May Ease Hot Flashes
Research suggests that Lexapro, an antidepressant medicine, can lower the number and severity of hot flashes in some menopausal women.
-
Government Experts Release New Osteoporosis Screening Guidelines
The U.S. Preventive Services Task Force has released new guidelines that call for more women to be screened for osteoporosis.
-
Chemo During Pregnancy Doesn’t Harm Baby
New research supports other studies that suggest that chemotherapy during pregnancy doesn't have harmful effects on the baby.
-
Xgeva Better Than Zometa at Reducing Risk of Breast Cancer Bone Problems
Research has found that Xgeva (chemical name: denosumab), a new targeted therapy medicine, is better than Zometa at lengthening the time before bone complications develop in women diagnosed with breast cancer that has spread to the bones.
-
Doctors Continue to Prescribe Standard-Dose Hormone Replacement Therapy
Despite a clear link between standard-dose HRT and breast cancer, many doctors continue to regularly prescribe standard-dose HRT instead of low-dose HRT.
-
Xgeva Slightly Better Than Zometa at Reducing Breast Cancer Bone Complications
Research has found that Xgeva (chemical name: denosumab), a new targeted therapy medicine, is somewhat better than Zometa at lowering the risk of bone complications in women diagnosed with breast cancer that has spread to the bones.
-
Fertility Counseling Before Cancer Treatment Boosts Quality of Life
Research suggests that young women who get fertility counseling before cancer treatment have fewer regrets and better overall quality of life after treatment compared to women who don't get fertility counseling.
-
Study Reinforces Link Between Breast Cancer Risk and Hormone Replacement Therapy
A new analysis of Women's Health Initiative data shows that women who use combination HRT are nearly twice as likely to die from breast cancer compared to women who don't use HRT.
